Typically in most cell types, the PERK/eIF2α pathway preferentially enhances the expression of activating transcription factor 4 (ATF4) and there are several reports of increased ATF4 gene expression in muscle during diabetes and renal failure (Harding et al. The gene discussed is ATF4; the disease is kidney failure.